NAFLD and HCC: Time to Bridge the Gap.
作者信息
Cholankeril George, Kanwal Fasiha
机构信息
Section of Gastroenterology and Hepatology, Department of Medicine, Baylor College of Medicine, Houston, TX.
Center for Innovations in Quality, Effectiveness and Safety, Michael E. DeBakey Veterans Affairs Medical Center, Houston, TX.
出版信息
Hepatology. 2021 Nov;74(5):2336-2338. doi: 10.1002/hep.32025. Epub 2021 Aug 30.
Abstract
摘要
相似文献
1
NAFLD and HCC: Time to Bridge the Gap.非酒精性脂肪性肝病与肝细胞癌：是时候弥合差距了。
Hepatology. 2021 Nov;74(5):2336-2338. doi: 10.1002/hep.32025. Epub 2021 Aug 30.
2
Hepatocellular carcinoma and non-alcoholic fatty liver disease.肝细胞癌与非酒精性脂肪性肝病。
Hepatol Int. 2019 Nov;13(6):688-694. doi: 10.1007/s12072-019-09995-8. Epub 2019 Nov 7.
3
NAFLD as a risk factor for HCC: new rules of engagement?非酒精性脂肪性肝病作为肝细胞癌的危险因素：新的作用机制？
Hepatol Int. 2016 Jul;10(4):533-4. doi: 10.1007/s12072-016-9731-8. Epub 2016 May 5.
4
Nonalcoholic fatty liver disease and hepatocellular carcinoma.非酒精性脂肪性肝病与肝细胞癌
Metabolism. 2016 Aug;65(8):1151-60. doi: 10.1016/j.metabol.2016.01.010. Epub 2016 Jan 23.
5
Long-term outcomes of non-alcoholic fatty liver disease and the risk factors for mortality and hepatocellular carcinoma in a Japanese population.在日本人群中，非酒精性脂肪性肝病的长期结局以及死亡和肝细胞癌的风险因素。
J Gastroenterol Hepatol. 2020 Sep;35(9):1579-1589. doi: 10.1111/jgh.14989. Epub 2020 Feb 5.
6
Risk of Hepatocellular Cancer in Patients With Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病患者的肝细胞癌风险。
Gastroenterology. 2018 Dec;155(6):1828-1837.e2. doi: 10.1053/j.gastro.2018.08.024. Epub 2018 Aug 23.
7
Rational HCC screening approaches for patients with NAFLD.非酒精性脂肪性肝病患者的肝癌合理筛查方法。
J Hepatol. 2022 Jan;76(1):195-201. doi: 10.1016/j.jhep.2021.08.028. Epub 2021 Sep 9.
8
Temporal trends, clinical patterns and outcomes of NAFLD-related HCC in patients undergoing liver resection over a 20-year period.20年间接受肝切除手术的非酒精性脂肪性肝病相关肝癌患者的时间趋势、临床模式及预后
Aliment Pharmacol Ther. 2017 Nov;46(9):856-863. doi: 10.1111/apt.14261. Epub 2017 Aug 31.
9
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病相关肝细胞癌的全球流行病学：趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):223-238. doi: 10.1038/s41575-020-00381-6. Epub 2020 Dec 21.
10
Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.非酒精性脂肪性肝病/非酒精性脂肪性肝炎与肝细胞癌。
Clin Liver Dis. 2018 Feb;22(1):201-211. doi: 10.1016/j.cld.2017.08.014.
引用本文的文献
1
Blood biomarkers of hepatocellular carcinoma: a critical review.肝细胞癌的血液生物标志物：一项批判性综述。
Front Cell Dev Biol. 2024 Nov 22;12:1489836. doi: 10.3389/fcell.2024.1489836. eCollection 2024.
2
The STING in Non-Alcoholic Fatty Liver Diseases: Potential Therapeutic Targets in Inflammation-Carcinogenesis Pathway.非酒精性脂肪性肝病中的STING：炎症-致癌途径中的潜在治疗靶点
Pharmaceuticals (Basel). 2022 Oct 9;15(10):1241. doi: 10.3390/ph15101241.
3
Serum 25-hydroxyvitamin D levels and the risk of non-alcoholic fatty liver: A two-sample Mendelian randomization study.血清 25-羟维生素 D 水平与非酒精性脂肪肝风险：一项两样本 Mendelian 随机研究。
Saudi J Gastroenterol. 2023 Jan-Feb;29(1):39-46. doi: 10.4103/sjg.sjg_297_22.
本文引用的文献
1
Preparing for the NASH Epidemic: A Call to Action.应对 NASH 流行：行动呼吁。
Gastroenterology. 2021 Sep;161(3):1030-1042.e8. doi: 10.1053/j.gastro.2021.04.074. Epub 2021 Jul 26.
2
Cancer Risk in Patients With Biopsy-Confirmed Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study.经活检证实的非酒精性脂肪性肝病患者的癌症风险：一项基于人群的队列研究。
Hepatology. 2021 Nov;74(5):2410-2423. doi: 10.1002/hep.31845. Epub 2021 Aug 25.
3
On the Proposed Definition of Metabolic-Associated Fatty Liver Disease.关于代谢相关脂肪性肝病的拟议定义。
Clin Gastroenterol Hepatol. 2021 May;19(5):865-870. doi: 10.1016/j.cgh.2021.01.017. Epub 2021 Jan 13.
4
Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.非酒精性脂肪性肝病相关肝细胞癌的全球流行病学：趋势、预测、危险因素和预防。
Nat Rev Gastroenterol Hepatol. 2021 Apr;18(4):223-238. doi: 10.1038/s41575-020-00381-6. Epub 2020 Dec 21.
5
Non-invasive stratification of hepatocellular carcinoma risk in non-alcoholic fatty liver using polygenic risk scores.利用多基因风险评分对非酒精性脂肪性肝病进行肝细胞癌风险的无创分层。
J Hepatol. 2021 Apr;74(4):775-782. doi: 10.1016/j.jhep.2020.11.024. Epub 2020 Nov 25.
6
Conceptual Model for the Hepatocellular Carcinoma Screening Continuum: Current Status and Research Agenda.肝癌筛查连续体的概念模型：现状与研究议程。
Clin Gastroenterol Hepatol. 2022 Jan;20(1):9-18. doi: 10.1016/j.cgh.2020.09.036. Epub 2020 Sep 19.
7
Effect of Metabolic Traits on the Risk of Cirrhosis and Hepatocellular Cancer in Nonalcoholic Fatty Liver Disease.代谢特征对非酒精性脂肪性肝病患者肝硬化和肝细胞癌风险的影响。
Hepatology. 2020 Mar;71(3):808-819. doi: 10.1002/hep.31014. Epub 2020 Feb 26.
8
Surveillance for Hepatocellular Carcinoma: Current Best Practice and Future Direction.肝细胞癌监测：当前最佳实践和未来方向。
Gastroenterology. 2019 Jul;157(1):54-64. doi: 10.1053/j.gastro.2019.02.049. Epub 2019 Apr 12.
9
Association between smoking and risk of bladder cancer among men and women.吸烟与男性和女性膀胱癌风险的关联。
JAMA. 2011 Aug 17;306(7):737-45. doi: 10.1001/jama.2011.1142.
Zotero 插件